A case study of the treatment strategies employed to cure a COVID-۱۹ patient with multiple infections successfully

The COVID-۱۹ pandemic has given rise to new clinical challenges in healthcare settings. One of these challenges includes a heightened risk of secondary invasive bacterial and fungal infections, which have been associated with a notable mortality rate. We report a fatal case of a COVID-۱۹ patient with two bacterial and one fungal infection successfully cured. A woman went to the hospital with fatigue, cough, chest and abdominal pain, nausea, and vomiting symptoms. She tested positive for COVID-۱۹ and had underlying health conditions. She had a bacterial infection called Klebsiella Pneumoniae. The bacteria was resistant to many antibiotics, but colistin was effective. After ۲۰ days in the ICU, she developed a fungal and Enterococcus faecalis (VRE) infection. The second bacteria was treated with linezolid. After ۳۵ days in the hospital, she was discharged with no signs of infection. Including appropriate bacterial screening and treatment is imperative when dealing with COVID-۱۹.CONCLUSIONTherefore, it is essential to incorporate proper bacterial screening and treatment in managing COVID-۱۹, especially for patients with co-morbidities like diabetes, hypertension and those with indwelling devices.

کلیدواژه ها:

COVID-۱۹ ، Klebsiella pneumoniae ، Enterococcus faecalis ، fungal infection ، case report.